# Lakeland Industries Inc: financial statements, quarterly

LAKE · Nasdaq · CIK 798081 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/lake.md) · [Financials](/companies/lake/financials.md) · [Filings](/companies/lake/filings.md) · [Insiders](/companies/lake/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lake/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [31.7](/filings/0001654954-24-015308.md) | [31.2 d](/filings/0001654954-25-004352.md) | [36.3](/filings/0001193125-25-137821.md) | [38.5](/filings/0001193125-25-199283.md) | [45.8](/filings/0001193125-25-312871.md) | [46.6 d](/filings/0001193125-26-159176.md) | [46.7](/filings/0001193125-26-264001.md) | [52.5](/filings/0001193125-26-386590.md) | [47.6](/filings/0001193125-25-312871.md) | [45.8 d](/filings/0001193125-26-159176.md) | [47.4](/filings/0001193125-26-264001.md) | [50.1](/filings/0001193125-26-386590.md) |
| Cost of revenue | $m | [18.3](/filings/0001654954-24-015308.md) | [20.0 d](/filings/0001654954-25-004352.md) | [20.1](/filings/0001193125-25-137821.md) | [23.3](/filings/0001193125-25-199283.md) | [27.2](/filings/0001193125-25-312871.md) | [27.9 d](/filings/0001193125-26-159176.md) | [31.1](/filings/0001193125-26-264001.md) | [33.7](/filings/0001193125-26-386590.md) | [33.5](/filings/0001193125-25-312871.md) | [31.1 d](/filings/0001193125-26-159176.md) | [32.5](/filings/0001193125-26-264001.md) | [31.6](/filings/0001193125-26-386590.md) |
| Gross profit | $m | [13.4](/filings/0001654954-24-015308.md) | [11.2 d](/filings/0001654954-25-004352.md) | [16.2](/filings/0001193125-25-137821.md) | [15.2](/filings/0001193125-25-199283.md) | [18.6](/filings/0001193125-25-312871.md) | [18.7 d](/filings/0001193125-26-159176.md) | [15.6](/filings/0001193125-26-264001.md) | [18.8](/filings/0001193125-26-386590.md) | [14.1](/filings/0001193125-25-312871.md) | [14.7 d](/filings/0001193125-26-159176.md) | [14.9](/filings/0001193125-26-264001.md) | [18.5](/filings/0001193125-26-386590.md) |
| Operating income | $m | [3.6](/filings/0001654954-24-015308.md) | [(3.3) d](/filings/0001654954-25-004352.md) | [2.2](/filings/0001193125-25-137821.md) | [(1.6)](/filings/0001193125-25-199283.md) | [0.8](/filings/0001193125-25-312871.md) | [(10.7) d](/filings/0001193125-26-159176.md) | [(4.6)](/filings/0001193125-26-264001.md) | [(4.0)](/filings/0001193125-26-386590.md) | [(1.6)](/filings/0001193125-25-312871.md) | [(5.2) d](/filings/0001193125-26-159176.md) | [2.3](/filings/0001193125-26-264001.md) | [(3.3)](/filings/0001193125-26-386590.md) |
| Interest expense | $m | [0.0](/filings/0001654954-24-015308.md) | [0.0 d](/filings/0001654954-25-004352.md) | [0.2](/filings/0001193125-25-137821.md) | [0.4](/filings/0001193125-25-199283.md) | [0.5](/filings/0001193125-25-312871.md) | [0.6 d](/filings/0001193125-26-159176.md) | [0.6](/filings/0001193125-26-264001.md) | [0.4](/filings/0001193125-26-386590.md) | [0.5](/filings/0001193125-25-312871.md) | [0.6 d](/filings/0001193125-26-159176.md) | [0.6](/filings/0001193125-26-264001.md) | [0.5](/filings/0001193125-26-386590.md) |
| Income tax | $m | [0.9](/filings/0001654954-24-015308.md) | [1.3 d](/filings/0001654954-25-004352.md) | [0.4](/filings/0001193125-25-137821.md) | [(0.4)](/filings/0001193125-25-199283.md) | [0.1](/filings/0001193125-25-312871.md) | [(0.4) d](/filings/0001193125-26-159176.md) | [(1.2)](/filings/0001193125-26-264001.md) | [(5.2)](/filings/0001193125-26-386590.md) | [13.7](/filings/0001193125-25-312871.md) | [0.4 d](/filings/0001193125-26-159176.md) | [1.3](/filings/0001193125-26-264001.md) | [1.2](/filings/0001193125-26-386590.md) |
| Net income | $m | [2.6](/filings/0001654954-24-015308.md) | [(1.0) d](/filings/0001654954-25-004352.md) | [1.7](/filings/0001193125-25-312871.md) | [(1.4)](/filings/0001193125-25-312871.md) | [0.1](/filings/0001193125-25-312871.md) | [(18.4) d](/filings/0001193125-26-159176.md) | [(3.9)](/filings/0001193125-26-386590.md) | [0.8](/filings/0001193125-26-386590.md) | [(16.0)](/filings/0001193125-25-312871.md) | [(6.2) d](/filings/0001193125-26-159176.md) | [0.4](/filings/0001193125-26-386590.md) | [(4.9)](/filings/0001193125-26-386590.md) |
| Diluted EPS | $ per share | [0.34](/filings/0001654954-23-015242.md) | not reported | [0.22](/filings/0001193125-25-137821.md) | [(0.19)](/filings/0001193125-25-199283.md) | [0.01](/filings/0001193125-25-312871.md) | not reported | [(0.41)](/filings/0001193125-26-264001.md) | [0.08](/filings/0001193125-26-386590.md) | [(1.64)](/filings/0001193125-25-312871.md) | not reported | [0.04](/filings/0001193125-26-264001.md) | [(0.50)](/filings/0001193125-26-386590.md) |
| Basic EPS | $ per share | [0.35](/filings/0001654954-23-015242.md) | not reported | [0.22](/filings/0001193125-25-137821.md) | [(0.19)](/filings/0001193125-25-199283.md) | [0.01](/filings/0001193125-25-312871.md) | not reported | [(0.41)](/filings/0001193125-26-264001.md) | [0.08](/filings/0001193125-26-386590.md) | [(1.64)](/filings/0001193125-25-312871.md) | not reported | [0.04](/filings/0001193125-26-264001.md) | [(0.50)](/filings/0001193125-26-386590.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | FY2024 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [25.2](/filings/0001654954-24-004465.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [104](/filings/0001654954-23-015242.md) | [102](/filings/0001654954-25-004352.md) | [114](/filings/0001654954-24-007442.md) | [129](/filings/0001654954-24-011569.md) | [125](/filings/0001654954-24-015308.md) | [137](/filings/0001193125-26-159176.md) | [141](/filings/0001193125-25-137821.md) | [147](/filings/0001193125-25-199283.md) | [143](/filings/0001193125-25-312871.md) | [134](/filings/0001193125-26-386590.md) | [137](/filings/0001193125-26-264001.md) | [137](/filings/0001193125-26-386590.md) |
| Total assets | $m | [148](/filings/0001654954-23-015242.md) | [154](/filings/0001654954-25-004352.md) | [172](/filings/0001654954-24-007442.md) | [198](/filings/0001654954-24-011569.md) | [201](/filings/0001654954-24-015308.md) | [213](/filings/0001193125-26-159176.md) | [218](/filings/0001193125-25-137821.md) | [226](/filings/0001193125-25-199283.md) | [221](/filings/0001193125-25-312871.md) | [210](/filings/0001193125-26-386590.md) | [212](/filings/0001193125-26-264001.md) | [207](/filings/0001193125-26-386590.md) |
| Current liabilities | $m | [15.5](/filings/0001654954-23-015242.md) | [18.3](/filings/0001654954-25-004352.md) | [21.1](/filings/0001654954-24-007442.md) | [30.3](/filings/0001654954-24-011569.md) | [29.6](/filings/0001654954-24-015308.md) | [34.9](/filings/0001193125-26-159176.md) | [36.3](/filings/0001193125-25-137821.md) | [40.2](/filings/0001193125-25-199283.md) | [37.5](/filings/0001193125-25-312871.md) | [38.0](/filings/0001193125-26-386590.md) | [44.4](/filings/0001193125-26-264001.md) | [45.9](/filings/0001193125-26-386590.md) |
| Total liabilities | $m | [24.7](/filings/0001654954-23-015242.md) | [30.3](/filings/0001654954-25-004352.md) | [46.4](/filings/0001654954-24-007442.md) | [73.7](/filings/0001654954-24-011569.md) | [76.5](/filings/0001654954-24-015308.md) | [65.9](/filings/0001193125-26-159176.md) | [74.7](/filings/0001193125-25-137821.md) | [79.0](/filings/0001193125-25-199283.md) | [86.2](/filings/0001193125-25-312871.md) | [80.8](/filings/0001193125-26-386590.md) | [81.8](/filings/0001193125-26-264001.md) | [81.4](/filings/0001193125-26-386590.md) |
| Long-term debt | $m | not reported | not reported | not reported | [2.9](/filings/0001654954-24-011569.md) | not reported | [16.4](/filings/0001193125-26-159176.md) | not reported | not reported | not reported | [30.4](/filings/0001193125-26-386590.md) | [25.8](/filings/0001193125-26-264001.md) | [26.9](/filings/0001193125-26-386590.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.9](/filings/0001193125-26-159176.md) | not reported | not reported | not reported | [1.9](/filings/0001193125-26-386590.md) | not reported | [1.8](/filings/0001193125-26-386590.md) |
| Short-term borrowings | $m | [0.0](/filings/0001654954-23-015242.md) | [0.3](/filings/0001654954-25-004352.md) | [0.0](/filings/0001654954-24-007442.md) | [0.0](/filings/0001654954-24-011569.md) | [0.0](/filings/0001654954-24-015308.md) | [0.9](/filings/0001654954-25-004352.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [124](/filings/0001654954-24-015308.md) | [123](/filings/0001193125-26-159176.md) | [125](/filings/0001193125-25-312871.md) | [125](/filings/0001193125-25-312871.md) | [125](/filings/0001193125-25-312871.md) | [147](/filings/0001193125-26-386590.md) | [143](/filings/0001193125-26-386590.md) | [147](/filings/0001193125-26-386590.md) | [134](/filings/0001193125-25-312871.md) | [129](/filings/0001193125-26-386590.md) | [131](/filings/0001193125-26-386590.md) | [125](/filings/0001193125-26-386590.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [3,829 d](/filings/0001654954-24-015308.md) | [3,179 d](/filings/0001654954-25-004352.md) | [293](/filings/0001193125-25-137821.md) | [(4,346) d](/filings/0001193125-25-199283.md) | [(8,441) d](/filings/0001193125-25-312871.md) | [(3,387) d](/filings/0001193125-26-159176.md) | [(4,841)](/filings/0001193125-26-264001.md) | [(4,819) d](/filings/0001193125-26-386590.md) | [(7,930) d](/filings/0001193125-25-312871.md) | [1,840 d](/filings/0001193125-26-159176.md) | [5,801](/filings/0001193125-26-264001.md) | [(404) d](/filings/0001193125-26-386590.md) |
| Capital expenditure | $k | [413 d](/filings/0001654954-24-015308.md) | [564 d](/filings/0001654954-25-004352.md) | [466](/filings/0001193125-25-137821.md) | [376 d](/filings/0001193125-25-199283.md) | [643 d](/filings/0001193125-25-312871.md) | [55.0 d](/filings/0001193125-26-159176.md) | [1,209](/filings/0001193125-26-264001.md) | [921 d](/filings/0001193125-26-386590.md) | [(1,346) d](/filings/0001193125-25-312871.md) | [(113) d](/filings/0001193125-26-159176.md) | [1,391](/filings/0001193125-26-264001.md) | [43.0 d](/filings/0001193125-26-386590.md) |
| Dividends paid | $k | [221 d](/filings/0001654954-24-015308.md) | [221 d](/filings/0001654954-25-004352.md) | [221](/filings/0001193125-25-312871.md) | [221](/filings/0001193125-25-312871.md) | [222](/filings/0001193125-25-312871.md) | [223 d](/filings/0001193125-26-159176.md) | [285](/filings/0001193125-26-386590.md) | [286](/filings/0001193125-26-386590.md) | [287](/filings/0001193125-25-312871.md) | [294 d](/filings/0001193125-26-159176.md) | [0.0](/filings/0001193125-26-264001.md) | [0.0 d](/filings/0001193125-26-386590.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-31) | Q1 FY2023 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7,705](/filings/0001654954-23-015242.md) | [7.5](/filings/0001654954-24-007442.md) | [7.6](/filings/0001654954-24-011569.md) | [7.6](/filings/0001654954-24-015308.md) | [7.6](/filings/0001193125-25-137821.md) | [7.4](/filings/0001193125-25-199283.md) | [7.7](/filings/0001193125-25-312871.md) | [9.5](/filings/0001193125-26-264001.md) | [10.1](/filings/0001193125-26-386590.md) | [9.8](/filings/0001193125-25-312871.md) | [10.3](/filings/0001193125-26-264001.md) | [9.9](/filings/0001193125-26-386590.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,931,346 at 2026-09-04, from the cover of the [10-Q filed 2026-09-09](/filings/0001193125-26-386590.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.